Antibody Discovery

Utilizing multiple technology platforms, LakePharma offers a range of services and solutions to identify novel monoclonal antibodies and determine their sequences. 

1. Hybridoma technology: comprehensive, customized hybridoma campaigns for therapeutic antibody discovery.

2. Naïve phage antibody libraries: LakePharma has licensed multiple naïve Fab libraries (XOMA, Moradec, etc.) and yeast display libraries, and employs them for unparalleled de novo antibody discovery.  

3. Clonal B cells: B cell clones or single cells can be used as the starting point for molecular cloning.

4. De novo sequencing: mass spectrometry can be used to sequence antibodies when the starting material is a pure monoclonal antibody and the source of DNA is not available.   

Please contact LakePharma at for custom quotes and details.